Total synthesis of [(2S)-Hiv2]didemnin M.
Liang
B
B
Department of Chemistry, University of Pennsylvania, Philadelphia 19104-6323, USA.
Vera
M D
MD
Joullié
M M
MM
D000818:Animals; D000890:Anti-Infective Agents / Q000138:chemical synthesis / Q000737:chemistry; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D047630:Depsipeptides; D007166:Immunosuppressive Agents / Q000138:chemical synthesis / Q000737:chemistry; D010456:Peptides, Cyclic / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D011500:Protein Synthesis Inhibitors / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D013237:Stereoisomerism; D014407:Tumor Cells, Cultured; D014561:Urochordata / Q000737:chemistry*
D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D047630:Depsipeptides; D007166:Immunosuppressive Agents; D010456:Peptides, Cyclic; D011500:Protein Synthesis Inhibitors; C415382:didemnin M, Hiv(2)-; C409142:tamandarin A; C030051:didemnins